on 11 May 2016
Last Applicant/ Owned by
ARENA PHARMACEUTICALS INC. A CORPORATION OF THE STATE OF DELAWARE
6166 Nancy Ridge DriveSan Diego, California 92121
US
Serial Number
1335374 filed on 14th Feb 2007
Correspondent Address
SCOTIA PLAZA40 KING STREET WEST40th FLOORTORONTO
ONTARIO
CA
M5H3Y2
Vienna Information
26 . 1 . 1
CirclesCercles
26 . 1 . 3
One circle or ellipseUn cercle ou une ellipse
26 . 1 . 24
Circles or ellipses with dark surfaces or parts of surfacesCercles ou ellipses avec surface ou partie de la surface foncée
26 . 11 . 1
One line or one bandUne ligne ou une bande
26 . 11 . 6
Thick lines, bandsLignes épaisses, bandes
26 . 11 . 12
Curved lines or bands (except a 26.11.13)Lignes ou bandes courbes (excepté a 26.11.13)
26 . 1 . 2
EllipsesEllipses
26 . 1 . 9
Ellipses containing one or more circles or polygons (except 26.1.10 and 26.1.11)Ellipses contenant un ou plusieurs cercles ou polygones (excepté 26.1.10 ou 26.1.11)
26 . 1 . 12
Circles or ellipses containing one or more other geometrical figures -- Note: Including circles or ellipses containing bent or straight lines (except 26.1.10).Cercles ou ellipses contenant une ou plusieurs autres figures géométriques -- Note: Y compris les cercles ou ellipses contenant des lignes courbées ou droites (excepté 26.1.10).
Trademark usage description
pharmaceutical preparations for the treatment of obesity, diabetes, sleep disorders, insomnia, thrombosis, platelet aggregation, dyslipidemia, atheros Read MoreCIPO Classification Code
Nice
CIPO Classification Code
Nice
CIPO Classification Code
Nice
1335374
Trademark
Action Taken | Status |
---|---|
Submitted for opposition 42 on 29th Apr 2009 | Advertised |
Submitted for opposition 26 on 23rd Apr 2009 | Approved |
Submitted for opposition 27 on 03rd Mar 2009 | Approval Notice Sent |
Submitted for opposition 15 on 25th Sep 2008 | Correspondence Created |
Submitted for opposition 22 on 27th Mar 2008 | Search Recorded |
Submitted for opposition 20 on 27th Mar 2008 | Examiner's First Report |
Submitted for opposition 15 on 27th Mar 2008 | Correspondence Created |
Submitted for opposition 1 on 15th Feb 2007 | Created |
Submitted for opposition 31 on 15th Feb 2007 | Formalized |
Submitted for opposition 30 on 14th Feb 2007 | Filed |